Treatment of CC that causes chronic heart failure is similar to that in non-Chagasic etiology. However, the efficacy of both drugs decreases the longer a person has been infected. Antiparasitic drugs are almost 100% effective in infected newborn babies and highly effective in the treatment of patients in the acute stage of the disease. Conclusions The diagnosis of CC in non-endemic areas requires a high index of suspicion and it is based on serology. She was discharged due to progressive improvement with cardiological treatment and implantable cardioverter defibrillator was placed 5 years later for the prevention of sudden cardiac death.

The patient referred positive serology for T. cruzi and polymerase chain reaction (PCR) was positive so benznidazole therapy was started. Dilated myocardiopathy with severe left ventricle dysfunction was diagnosed. Cesarean section was performed and maternal hypotension and uterine atony occurred. Case presentation Bolivian woman at 38 weeks of gestation was admitted at the emergency room with the diagnosis of congestive heart failure. Chagasic cardiomyopathy (CC) is the most serious complication of the chronic phase of CD and the major cause of morbidity and mortality among patients with CD. CD is now found in areas receiving migrant populations where no vector-borne transmission occurs. Objectives Chagas disease (CD) is caused by infection with the protozoan Trypanosoma cruzi, a parasite that nests in various tissues, causing irreversible cardiac damage in 30% of patients with chronic disease and neurological or digestive lesions in 10%.

Matrix absence management rossana